CRISPR has been heralded as the next frontier in medicine and wellness. The gene-editing technology has the potential to end hereditary diseases like Huntington's, and has already been used to improve agriculture and eliminate HIV in mice. But the more scientists have been experimenting with it, the more they are finding that CRISPR is far from foolproof.
In June, two studies published in Nature Medicine demonstrated that cells altered with CRISPR may be missing key anti-cancer mechanisms, increasing the risk that those cells will initiate tumors. Last week, research published in Nature Biotechnology added to these concerns by showing that CRISPR can mess up a cell’s genetic material even worse than previously thought.
We talked to Motherboard's Daniel Oberhaus about what this research means for the future of CRISPR.
You can catch The VICE Guide to Right Now Podcast on Acast, Google Play, Apple Podcasts, Stitcher, or wherever you get your podcasts. And sign up for our newsletter to get the best of VICE delivered to your inbox daily.